Nutex Health, Inc. Annual Deferred Income Tax Expense (Benefit) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Nutex Health, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2017 to 2023.
  • Nutex Health, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$95.4K, a 89.5% increase year-over-year.
  • Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$5.71M, a 214% decline from 2022.
  • Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $5M.
  • Nutex Health, Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was -$985K.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$5.71M -$10.7M -214% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $5M +$5.98M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$985K -$985K Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2018 $392K $0 0% Jan 1, 2018 Dec 31, 2018 10-K/A 2019-04-17
2017 $392K Jan 1, 2017 Dec 31, 2017 10-K 2018-04-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.